Baxter Healthcare Corp., Deerfield, Ill., will buy the generic injectable-drug business of Wyeth, Madison, N.J., for approximately $305 million. Subject to regulatory approval, the deal calls for Baxter to acquire Wyeth's ESI Lederle division, including a 330,000-square-foot manufacturing facility and 1,000 new employees in Cherry Hill, N.J.
Baxter to buy Wyeth's injectable-drug business
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.